BIO-RAD laboratories:1110109 [14-025739]
Ended Awarded Last action
- Contract number
- HHSN26100013
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,133
Award facts
- Contract value 100% obligated
- $1,133.06 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price Redetermination
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$2,266 | |
| Original award | $3,399 |
About this award
Bio-Rad Laboratories, Inc. was awarded a contract by the National Cancer Institute on March 27, 2014, with an ultimate completion date of April 19, 2015. This contract was executed as a Blanket Purchase Agreement (BPA) call under a fixed price redetermination pricing structure with a ceiling value of $1,133.06. The award was not designated as a small business set-aside. The work is to be performed in Bethesda, Maryland, and represents a call order against Bio-Rad's existing BPA vehicle with the National Institutes of Health for procurement of biological materials, laboratory supplies, and specialized scientific equipment. Bio-Rad Laboratories, Inc., headquartered in Hercules, California, is a global leader in life science research and clinical diagnostics, supplying the federal government with advanced laboratory instrumentation, reagents, and consumables.
This contract supports the National Cancer Institute's research operations through Bio-Rad's Life Science Group Division, which specializes in sophisticated laboratory technologies including polymerase chain reaction (PCR) systems, thermal cyclers, droplet digital PCR instruments, and diagnostic reagents. Bio-Rad's extensive portfolio of federal contracts reflects its established position as a large, competitive contractor supplying critical scientific instrumentation across multiple government agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Defense. The company holds a significant $10 million single-award BPA with the NIH Office of Logistics and Acquisition Operations, which facilitates efficient procurement of specialized equipment and consumables supporting federal research activities through individual call orders such as this award.
Quick answers
Who was awarded contract HHSN26100013?
HHSN26100013 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on March 27, 2014.
How much is contract HHSN26100013 worth?
The government has obligated $1,133 on HHSN26100013.
Is contract HHSN26100013 an order under another contract?
Yes. HHSN26100013 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100013 competed?
The extent of competition for HHSN26100013 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award